In the article on TRPV6 in breast cancer in the February 2008 (1) issue, the text in the legend to Fig. 4A and B on page 276 was incorrect. The correct Fig. 4 and legend appear below.

Figure 4.

A, dose-dependent effect of tamoxifen (1 nM, 10 nM, 100 nM, 1 μM, and 1 μM) on TRPV6 mRNA expression in T47D cells after 24 h determined via real-time PCR. B, dose-dependent effect of 1α,25 dihydroxyvitamin D (100 nmol/L, 10 nmol/L, 1 nmol/L, and 100 pmol/L) on TRPV6 mRNA expression in T47D cells after 24 h determined via real-time PCR. Data shown are percent change in TRPV6 mRNA compared with vehicle only control. Columns, mean; bars, SD (n = 3).

Figure 4.

A, dose-dependent effect of tamoxifen (1 nM, 10 nM, 100 nM, 1 μM, and 1 μM) on TRPV6 mRNA expression in T47D cells after 24 h determined via real-time PCR. B, dose-dependent effect of 1α,25 dihydroxyvitamin D (100 nmol/L, 10 nmol/L, 1 nmol/L, and 100 pmol/L) on TRPV6 mRNA expression in T47D cells after 24 h determined via real-time PCR. Data shown are percent change in TRPV6 mRNA compared with vehicle only control. Columns, mean; bars, SD (n = 3).

Close modal
1
Bolanz KA, Hediger MA, Landowski CP. The role of TRPV6 in breast carcinogenesis.
Mol Cancer Ther
2008
;
7
:
271
–9.